Models

Dataset Information

0

Cappuccio2006 - Cancer immunotherapy by interleukin-21


ABSTRACT: This model describes the effects of Il-21 on tumor eradication via natural killer cell-mediated and CD8+ T-cell-mediated lysis of tumor cells. The model demonstrates changes in growth dynamics in nonimmunogenic B16 melanoma and the immunogenic MethA and MCA205 fibrosarcomas, showing a strong dependence of the NK-cell/CD8+ T-cell balance on tumor immunogenicity.

SUBMITTER: Johannes Meyer  

PROVIDER: BIOMD0000000761 | BioModels | 2024-09-02

REPOSITORIES: BioModels

altmetric image

Publications

Cancer immunotherapy by interleukin-21: potential treatment strategies evaluated in a mathematical model.

Cappuccio Antonio A   Elishmereni Moran M   Agur Zvia Z  

Cancer research 20060701 14


The newly characterized interleukin (IL)-21 plays a central role in the transition from innate immunity to adaptive immunity and shows substantial tumor regression in mice. IL-21 is now developed as a cancer immunotherapeutic drug, but conditions for efficacious therapy, and the conflicting immunostimulatory and immunoinhibitory influence of the cytokine, are yet to be defined. We studied the effects of IL-21 on tumor eradication in a mathematical model focusing on natural killer (NK) cell-media  ...[more]

Similar Datasets

2023-12-21 | GSE209945 | GEO
2023-04-19 | PXD040957 | Pride
| 2669507 | ecrin-mdr-crc
2023-11-02 | GSE243814 | GEO
2023-11-02 | GSE236680 | GEO
2023-11-02 | GSE236673 | GEO
2023-11-02 | GSE236674 | GEO
2007-11-01 | E-MEXP-1284 | biostudies-arrayexpress
| 2669506 | ecrin-mdr-crc
2007-12-01 | E-MEXP-1285 | biostudies-arrayexpress